453 related articles for article (PubMed ID: 27761978)
1. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
Tzouvelekis A; Herazo-Maya JD; Slade M; Chu JH; Deiuliis G; Ryu C; Li Q; Sakamoto K; Ibarra G; Pan H; Gulati M; Antin-Ozerkis D; Herzog EL; Kaminski N
Respirology; 2017 Apr; 22(3):486-493. PubMed ID: 27761978
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
Sokai A; Handa T; Tanizawa K; Oga T; Uno K; Tsuruyama T; Kubo T; Ikezoe K; Nakatsuka Y; Tanimura K; Muro S; Hirai T; Nagai S; Chin K; Mishima M
Respir Res; 2015 Sep; 16():120. PubMed ID: 26415518
[TBL] [Abstract][Full Text] [Related]
3. Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.
Song JW; Do KH; Jang SJ; Colby TV; Han S; Kim DS
Chest; 2013 May; 143(5):1422-1429. PubMed ID: 23715088
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.
Richards TJ; Kaminski N; Baribaud F; Flavin S; Brodmerkel C; Horowitz D; Li K; Choi J; Vuga LJ; Lindell KO; Klesen M; Zhang Y; Gibson KF
Am J Respir Crit Care Med; 2012 Jan; 185(1):67-76. PubMed ID: 22016448
[TBL] [Abstract][Full Text] [Related]
5. [
Justet A; Laurent-Bellue A; Thabut G; Dieudonné A; Debray MP; Borie R; Aubier M; Lebtahi R; Crestani B
Respir Res; 2017 Apr; 18(1):74. PubMed ID: 28449678
[TBL] [Abstract][Full Text] [Related]
6. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
[TBL] [Abstract][Full Text] [Related]
7. Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.
White ES; Xia M; Murray S; Dyal R; Flaherty CM; Flaherty KR; Moore BB; Cheng L; Doyle TJ; Villalba J; Dellaripa PF; Rosas IO; Kurtis JD; Martinez FJ
Am J Respir Crit Care Med; 2016 Nov; 194(10):1242-1251. PubMed ID: 27149370
[TBL] [Abstract][Full Text] [Related]
8. The predictors of mortality in IPF - Does emphysema change the prognosis?
Tokgoz Akyıl F; Sevim T; Akman C; Aksoy E; Ağca M; Aktas O; Akyıl M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):267-274. PubMed ID: 27758993
[TBL] [Abstract][Full Text] [Related]
9. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
[TBL] [Abstract][Full Text] [Related]
10. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L
Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
[TBL] [Abstract][Full Text] [Related]
12. Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.
Serajeddini H; Rogliani P; Mura M
Lung; 2018 Dec; 196(6):707-713. PubMed ID: 30151723
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568
[TBL] [Abstract][Full Text] [Related]
14. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.
Maher TM; Oballa E; Simpson JK; Porte J; Habgood A; Fahy WA; Flynn A; Molyneaux PL; Braybrooke R; Divyateja H; Parfrey H; Rassl D; Russell AM; Saini G; Renzoni EA; Duggan AM; Hubbard R; Wells AU; Lukey PT; Marshall RP; Jenkins RG
Lancet Respir Med; 2017 Dec; 5(12):946-955. PubMed ID: 29150411
[TBL] [Abstract][Full Text] [Related]
15. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline.
Salisbury ML; Xia M; Zhou Y; Murray S; Tayob N; Brown KK; Wells AU; Schmidt SL; Martinez FJ; Flaherty KR
Chest; 2016 Feb; 149(2):491-498. PubMed ID: 26425858
[TBL] [Abstract][Full Text] [Related]
17. Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients.
Salisbury ML; Tolle LB; Xia M; Murray S; Tayob N; Nambiar AM; Schmidt SL; Lagstein A; Myers JL; Gross BH; Kazerooni EA; Sundaram B; Chughtai AR; Martinez FJ; Flaherty KR
Respir Med; 2017 Oct; 131():229-235. PubMed ID: 28947036
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.
Jenkins RG; Simpson JK; Saini G; Bentley JH; Russell AM; Braybrooke R; Molyneaux PL; McKeever TM; Wells AU; Flynn A; Hubbard RB; Leeming DJ; Marshall RP; Karsdal MA; Lukey PT; Maher TM
Lancet Respir Med; 2015 Jun; 3(6):462-72. PubMed ID: 25770676
[TBL] [Abstract][Full Text] [Related]
19. [Change of matrix metalloproteinase-1 and matrix metalloproteinase-7 in serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and sarcoidosis].
Zhou LF; Jiang L; Li ZH; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun; 33(6):441-4. PubMed ID: 20979817
[TBL] [Abstract][Full Text] [Related]
20. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.
Zappala CJ; Latsi PI; Nicholson AG; Colby TV; Cramer D; Renzoni EA; Hansell DM; du Bois RM; Wells AU
Eur Respir J; 2010 Apr; 35(4):830-6. PubMed ID: 19840957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]